Prevalence and risk factors of interstitial lung disease in early systemic sclerosis and systemic sclerosis sine scleroderma: a cross-sectional study.

IF 1.4 4区 医学 Q3 RHEUMATOLOGY
ARP Rheumatology Pub Date : 2025-01-01
Maria Carolina Torres Villarreal, Luis Javier Cajas Santana
{"title":"Prevalence and risk factors of interstitial lung disease in early systemic sclerosis and systemic sclerosis sine scleroderma: a cross-sectional study.","authors":"Maria Carolina Torres Villarreal, Luis Javier Cajas Santana","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Introduction: Interstitial lung involvement (ILD) is one of the main complications in patients with systemic sclerosis (SSc), representing a significant cause of mortality. According to previous reports, ILD can appear in many patients from early stages (eSSc) to patients with established disease without skin involvement (ssSSc).</p><p><strong>Methods: </strong>Patients were included in the ssSSc group if they met the ACR/EULAR 2013 classification criteria and had a Rodnan skin score 0. In the eSSc group, if they did not meet the former criteria but fulfilled the VEDOSS criteria. Patients must have undergone a high-resolution chest CT scan within the last six months. Experts in this complication reviewed the images, and the percentage of patients with ILD in each group was determined. A univariate and multivariate analysis was performed to determine potential risk factors for ILD, including conventional risk factors and clinical findings in both groups. Odds Ratios and their 95% confidence intervals were estimated. Statistical significance was considered when p was less than 0.05.</p><p><strong>Results: </strong>Data from 353 patients with SSc: 65 (18.4%) with ssSSc, and 75 (21.2%) eSSc (VEDOSS patients) were included in the study. The proportion of patients with ILD was 38% in the ssSSc group and 20% in VEDOSS patients group (p=0.03). Regarding risk factors, anticentromere antibody positivity was found to have a protective effect (OR 0.17, 95% CI 0.03-0.44, p=0.001), and anti-SCL-70 antibody presence was identified as a risk factor for ILD (OR 35.8, 95% CI 2.6-492, p=0.007). No association was found with male gender, digital ulcers, puffy fingers, or capillaroscopic findings.</p><p><strong>Conclusions: </strong>ILD in patients with SSc can occur from early stages or without skin involvement. Thus, an active search for ILD is warranted, as it can be present in 1 out of 5 patients with these disease subsets.</p>","PeriodicalId":29669,"journal":{"name":"ARP Rheumatology","volume":"4 1","pages":"5-12"},"PeriodicalIF":1.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ARP Rheumatology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Introduction: Interstitial lung involvement (ILD) is one of the main complications in patients with systemic sclerosis (SSc), representing a significant cause of mortality. According to previous reports, ILD can appear in many patients from early stages (eSSc) to patients with established disease without skin involvement (ssSSc).

Methods: Patients were included in the ssSSc group if they met the ACR/EULAR 2013 classification criteria and had a Rodnan skin score 0. In the eSSc group, if they did not meet the former criteria but fulfilled the VEDOSS criteria. Patients must have undergone a high-resolution chest CT scan within the last six months. Experts in this complication reviewed the images, and the percentage of patients with ILD in each group was determined. A univariate and multivariate analysis was performed to determine potential risk factors for ILD, including conventional risk factors and clinical findings in both groups. Odds Ratios and their 95% confidence intervals were estimated. Statistical significance was considered when p was less than 0.05.

Results: Data from 353 patients with SSc: 65 (18.4%) with ssSSc, and 75 (21.2%) eSSc (VEDOSS patients) were included in the study. The proportion of patients with ILD was 38% in the ssSSc group and 20% in VEDOSS patients group (p=0.03). Regarding risk factors, anticentromere antibody positivity was found to have a protective effect (OR 0.17, 95% CI 0.03-0.44, p=0.001), and anti-SCL-70 antibody presence was identified as a risk factor for ILD (OR 35.8, 95% CI 2.6-492, p=0.007). No association was found with male gender, digital ulcers, puffy fingers, or capillaroscopic findings.

Conclusions: ILD in patients with SSc can occur from early stages or without skin involvement. Thus, an active search for ILD is warranted, as it can be present in 1 out of 5 patients with these disease subsets.

间质性肺疾病在早期系统性硬化症和硬皮病后系统性硬化症中的患病率和危险因素:一项横断面研究。
简介:肺间质受累(ILD)是系统性硬化症(SSc)患者的主要并发症之一,是导致死亡的重要原因。根据以前的报道,ILD可以出现在许多患者中,从早期阶段(eSSc)到已确定的无皮肤累及的疾病(ssSSc)。方法:符合ACR/EULAR 2013分类标准且罗德曼皮肤评分为0分的患者纳入ssSSc组。在esc组中,如果他们不符合前一个标准,但满足VEDOSS标准。患者必须在过去六个月内接受过高分辨率胸部CT扫描。该并发症的专家审查了图像,并确定了每组中ILD患者的百分比。进行单因素和多因素分析以确定ILD的潜在危险因素,包括两组的常规危险因素和临床表现。估计比值比及其95%置信区间。p < 0.05为差异有统计学意义。结果:353例SSc患者的数据:65例(18.4%)ssSSc和75例(21.2%)eSSc (VEDOSS患者)纳入研究。ssSSc组和VEDOSS组的ILD患者比例分别为38%和20% (p=0.03)。关于危险因素,抗着丝粒抗体阳性被发现具有保护作用(OR 0.17, 95% CI 0.03-0.44, p=0.001),抗scl -70抗体存在被确定为ILD的危险因素(OR 35.8, 95% CI 2.6-492, p=0.007)。与男性、手指溃疡、手指浮肿或毛细血管镜检查结果无关联。结论:SSc患者的ILD可以发生在早期或不累及皮肤。因此,有必要积极寻找ILD,因为患有这些疾病亚群的患者中有五分之一可能存在ILD。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信